GLPwatch
Trials (2101)
Page 29 of 36.
- Novel Therapeutics and Endothelial Dysfunction in T1DM Patients
- The Effect of Semaglutide on Bone Health
- A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation IV
- Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results
- A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants
- A Study of Bimagrumab Alone (LY3985863) and Bimagrumab With Tirzepatide (LY900042) in Healthy Participants
- Special Use - Results Surveillance on Long-term Use With Wegovy®
- A Research Study to Compare Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity
- Body Composition and Exercise to Prevent Muscle Loss With GLP1 Agonist Treatment
- Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2D
- A Study of Tirzepatide (LY3298176) in Healthy Participants
- A Study Comparing the Effect of Albiglutide With Exenatide on Regional Brain Activity Related to Nausea in Healthy Subjects
- A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both
- Safety Study of Weekly Semaglutide in Chilean Participants With Type 2 Diabetes
- Improved Treatment and Monitoring of Alzheimer's Disease
- Emulation of the STEP-HFpEF DM Heart Failure Trial in Healthcare Claims Data
- Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity
- Medically Reproducing Bariatric Surgery
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical Practice
- Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke After Endovascular Treatment
- Beta Cell Imaging During and Shortly After the Honeymoon Phase of T1D
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Sulfonylurea
- A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- Semaglutide 2.4mg for Low Responders After Bariatric Surgery
- Gut Microbiome Changes Following Liraglutide Treatment in Obese Subjects or Overweight Subjects With Co-morbidities
- Epicardial Adipose Tissue Composition and Heart Failure With Preserved Ejection Fraction
- Efficacy and Safety of LixiLan Versus Insulin Glargine Alone Both With Metformin in Japanese With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Drugs
- A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes
- A Study of LY3305677 in Healthy Participants
- Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity
- A Research Study, Looking at How Xultophy® Works in People With Type 2 Diabetes in Local Clinical Practice in United Arab Emirates
- Lifestyle Intervention to Reduce the Risk of Sarcopenia in Adults With Diabetes & Obesity Treated With Semaglutide
- Liraglutide in Spinal Fluid
- Semaglutide and Dapagliflozin in Diabetic Patients With Different Pathophysiology
- A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, and Effect of GLP-1 Drug Semaglutide on Midazolam Blood Levels in Healthy Adults With Weight in the Obesity Range
- Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF
- Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus.
- Gastric Content in Fasting Volunteers and in Tirzepatide Users: an Observational and Cross-sectional Study
- The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
- Oat Flakes β-glucan on Glycemic Variability, Pancreatic Reserve, and Dyslipidemia Among Adolescents With Type 1 Diabetes
- Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)
- Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
- Semaglutide Use in Acute Pulmonary Embolism
- Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients With Type 2 Diabetes
- The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
- Liraglutide in Type 1 Diabetes
- A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity
- Quality of Life and Fixed-ratio Combination of Insulin Degludec and Liraglutide (iDegLira)
- Exenatide for Stress Hyperglycemia
- Effects of Glucagon-Like Peptide-1 Analogs on Sexuality
- Simplification of Complex Insulin Regimens With Preserving Good Glycemic Control in Type 2 Diabetes
- The Effects of Semaglutide on Body Composition and Performance in Military Personnel
- A Study of IBI362 in Subjects With HFpEF or HFmrEF Combined With Obesity
- Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of Obesity
- A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice (SURE GERMANY)
- Exenatide and Brown Adipose Tissue
- Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia
- A Research Study Looking at Similarity Between Tirzepatide Versions for Different Injection Devices
- Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study)
- COMBinAtion Therapy in Myocardial Infarction: The COMBAT-MI Trial